NCT06900790

Brief Summary

The goal of this observational study is to evaluate the long-term effects of ERCP and surgery in pediatric patients with pancreatic duct stones. The main objective is to determine the optimal treatment choice(ERCP or surgery) for children with pancreatic duct stones and identify the appropriate timing for surgery in patients who have undergone multiple ERCP procedures, in order to avoid adverse outcomes caused by repeated trauma to the duodenal papilla. Last updated on January 24, 2025.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Apr 2025

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 23, 2025

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 28, 2025

Completed
26 days until next milestone

Study Start

First participant enrolled

April 23, 2025

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 23, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 23, 2025

Completed
Last Updated

March 28, 2025

Status Verified

March 1, 2025

Enrollment Period

8 months

First QC Date

March 23, 2025

Last Update Submit

March 23, 2025

Conditions

Keywords

pancreatic duct stonesERCPFrey surgery

Outcome Measures

Primary Outcomes (3)

  • stone clearance

    The stone clearance rate refers to the proportion of patients confirmed by postoperative imaging (MRCP) to have no residual pancreatic duct stones.

    From intervention to the end of treatment at 1 week

  • complication rate

    The complication rate refers to the incidence of pancreatitis following ERCP and associated procedures, as well as pancreatic fistula, bile leakage, and the necessity for prolonged drainage after the Frey procedure.

    From enrollment to the end of treatment at 2 weeks

  • reintervention rate

    The reintervention rate refers to the proportion of patients who required additional invasive procedures (either ERCP or surgery) after the initial treatment.

    From enrollment to the end of treatment at 1 year.

Study Arms (2)

ERCP group

Pediatric pancreatic duct stone patients who underwent ERCP to restore pancreatic duct patency.

Procedure: ERCP

Surgery group

Pediatric pancreatic duct stone patients who underwent Frey surgery.

Procedure: ERCP

Interventions

ERCPPROCEDURE

There are two intervention methods for pediatric pancreatic duct stones. One is to remove the pancreatic duct stones through Endoscopic Retrograde Cholangiopancreatography(ERCP), while simultaneously dilating the pancreatic duct and placing a stent to assist in the normal drainage of pancreatic juice. The other is local resection of the pancreatic head combined with longitudinal pancreaticojejunostomy (Frey surgery).

Also known as: Frey surgery
ERCP groupSurgery group

Eligibility Criteria

Age2 Months - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Children and adolescents (≤18 years old) diagnosed with pancreatic duct stones between 2015 and 2025 at a single tertiary care center. Data includes patients who underwent ERCP or surgery when the first treatment.

You may qualify if:

  • Patients aged 0 to 18 years
  • Diagnosed with pancreatic duct stones by imaging (e.g., ultrasound, CT, MRCP)
  • Treated and followed at pediatric surgery, west china hospital, between 2014 and 2025
  • Complete clinical data available for review

You may not qualify if:

  • Pancreatic duct stones secondary to previous pancreatic or biliary surgery
  • Concurrent severe systemic diseases (e.g., advanced cardiac, renal, or hepatic disease)
  • Incomplete or missing key clinical records

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Cholangiopancreatography, Endoscopic Retrograde

Intervention Hierarchy (Ancestors)

CholangiographyRadiography, AbdominalRadiographyDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisDiagnostic Techniques, Digestive SystemEndoscopy, Digestive SystemEndoscopyDiagnostic Techniques, SurgicalDigestive System Surgical ProceduresSurgical Procedures, OperativeMinimally Invasive Surgical Procedures

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
M.Med

Study Record Dates

First Submitted

March 23, 2025

First Posted

March 28, 2025

Study Start

April 23, 2025

Primary Completion

December 23, 2025

Study Completion

December 23, 2025

Last Updated

March 28, 2025

Record last verified: 2025-03